FDA Study Shows Statins Don’t Increase Risk of ALS - Health Blog - WSJ

Links shared publicly online about this topic.

  • 2,587
    total visits

FDA Study Shows Statins Don’t Increase Risk of ALS - Health Blog - WSJ

feeds.wsjonline.com

Sporadic reports had suggested the cholesterol drugs could be tied to ALS, also known as Lou Gehrig's Disease. But an FDA analysis suggests the drugs don't increase the risk of the disease.

View full resource at feeds.wsjonline.com

Tags: Cholesterol, Cholesterol Medication, ALS, Disease and Condition, Drug, FDA

  • Share

Most Recently Shared on September 30, 2008 at 1:01 pm By:

WSJHealthBlog WSJ Health Blog

FDA Study Shows Statins Don’t Increase Risk of ALS http://tinyurl.com/3pyq4u

4 years ago...

Most at-risk patients don't adhere to statin treatment, despite real benefits

sciencedaily.com — “The vast majority of patients at high risk for heart disease or stroke do a poor job of taking statins as prescribed, a new study suggests. That's especially unfortunate, because the same study shows that taking statins can significantly increase the quality and length of those patients' lives.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on May 24, 2011 at 11:39 am By:

rvaughnmd Richard Vaughn MD Doctor, Health Executive, Health IT, and Physician

Only 48% taking statin on a regular basis after one year, dips to 27% after 10 years," http://goo.gl/6Fp8I via @JFahrni #nonadherence

11 months ago...

Despite Real Benefits, Most At-Risk Patients Don't Adhere To Statin Treatment

medicalnewstoday.com — “A new study from North Carolina State University shows that the vast majority of patients at high risk for heart disease or stroke do a poor job of taking statins as prescribed. That's especiallyView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 13, 2011 at 10:05 am By:

mnt_statins MNT Statins News Health News

Despite Real Benefits, Most At-Risk Patients Don't Adhere To Statin Treatment http://mnt.to/3VPG #statins

11 months ago...

Study: Most at-risk patients don't adhere to statin treatment, despite real benefits

medicalxpress.com — “A new study from North Carolina State University shows that the vast majority of patients at high risk for heart disease or stroke do a poor job of taking statins as prescribed. That's especially unfortunate, because the same study shows that taking statins can significantly increase the quality and ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on May 12, 2011 at 2:08 pm By:

physorg_health PhysOrg Health News Health News

Study: Most at-risk patients don't adhere to statin treatment, despite real benefits http://tw.medicalxpress.com/224413674

11 months ago...

Statins May Not Prevent Heart Disease in Healthy Individuals - TIME Healthland

healthland.time.com — “Cholesterol-lowering drugs known as statins are an undeniable boon for heart patients. Study after study has shown that for those who have had a heart attack or other forms of heart disease, the medications can significantly lower the risk of future heart trouble.View full resource at healthland.time.com

  • View Related
  • Share

Most Recently Shared on January 21, 2011 at 12:54 am By:

HeartDisease_OW Heart Disease OW OW Health

Statins May Not Prevent Heart Disease in Healthy People: When it comes to healthy individuals who don't yet show... http://bit.ly/go6hiU

1 year ago...

FDA Moves To Pull Approval Of Avastin For Breast Cancer : Shots - Health News Blog : NPR

npr.org — “The Food and Drug Administration says data from recent clinical studies show the benefits of the drug Avastin for breast cancer patients don't outweigh the risks. Roche's Genentech unit disagrees and wants to keep marketing the drug for that use.View full resource at npr.org

  • View Related
  • Share

Most Recently Shared on December 17, 2010 at 12:09 am By:

FDA Moves To Pull Approval Of Avastin For Breast Cancer : Shots - Health News Blog : NPR

npr.org — “The Food and Drug Administration says data from recent clinical studies show the benefits of the drug Avastin for breast cancer patients don't outweigh the risks. Roche's Genentech unit disagrees and wants to keep marketing the drug for that use.View full resource at npr.org

  • View Related
  • Share

Most Recently Shared on December 16, 2010 at 8:34 pm By:

NPRHealth NPR Health News Health News

FDA Moves To Pull Approval Of Avastin For Breast Cancer http://n.pr/fcBylo

1 year ago...

Epilepsy Drugs Don’t Raise Suicide Risk, Study Shows --Doctors Lounge

doctorslounge.com — “Epilepsy Drugs Don’t Raise Suicide Risk, Study Shows --Doctors LoungeView full resource at doctorslounge.com

  • View Related
  • Share

Most Recently Shared on August 6, 2010 at 6:29 pm By:

Neurology_OW Neurology OW OW Health

Epilepsy Drugs Don’t Raise Suicide Risk, Study Shows: Experts say findings should prompt FDA to remove warning lab... http://bit.ly/amHD8c

2 years ago...

Epilepsy Drugs Don't Raise Suicide Risk, Study Shows

businessweek.com — “Experts say findings should prompt FDA to remove warning label on medicationsView full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on August 5, 2010 at 12:17 am By:

HealthHive Health News Health News

Epilepsy Drugs Don't Raise Suicide Risk, Study Shows http://bit.ly/aR6wXq

2 years ago...

FDA says follow-up studies of Avastin don't show benefit for breast cancer patients | StarTribune.com

startribune.com — “FDA says follow-up studies of Avastin don't show benefit for breast cancer patients | StarTribune.comView full resource at startribune.com

  • View Related
  • Share

Most Recently Shared on July 16, 2010 at 3:37 pm By:

Health_SS Susan S Health Advocate

FDA says follow-up studies of Avastin don't show benefit for breast cancer patients: http://bit.ly/az7Q64

2 years ago...

2 New Drugs May Fight Multiple Sclerosis#1 - WEGO Health

community.wegohealth.com — “2 New Drugs May Fight Multiple Sclerosis#1 2 New Drugs May Fight Multiple Sclerosis#1 Study Shows Cladribine and Fingolimod Cut Relapse Rate in MS Patients By Charlene Laino WebMD Health News Reviewed by Louise Chang, MD April 30, 2009 (Seattle) -- Two new oral drugs cut by about half the relapse rate in people with multiple sclerosis (MS). If approved by the FDA, the drugs -- cladribine and fingolimod -- would become the first treatments for MS that don't involve regular injections or infusionsView full resource at community.wegohealth.com

  • View Related
  • Share

Most Recently Shared on November 30, 2009 at 7:28 am By:

iHealthTube.com - Video - The FDA and Big Pharmacy Hide Negative Studies

ihealthtube.com — “Mark Hyman, M.D. is upset at the fact that the FDA and Big Pharmacy only publish positive information on prescription drugs. The studies that show negative results or that the drugs don't work, simply are not published. He finishes by saying that prescription drugs are not the answers to your health problems.View full resource at ihealthtube.com

  • View Related
  • Share

Most Recently Shared on November 27, 2009 at 6:15 pm By:

ihealthtube iHealthTube.com Health Site

iHealthTube.com - Video - The FDA and Big Pharmacy Hide Negative Studies http://ow.ly/Gg8e

2 years ago...

Low HDL cholesterol

theheart.org — “Researchers say a new study shows that statins don't alter the risks associated with low HDL-cholesterol levels and that raising HDL cholesterol 10mg/dL could prevent an additional eight MIs per 1000 patient-years.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on November 17, 2009 at 8:33 pm By:

theheartorg Shelley Wood Cardiology

Statins do not eliminate risk of low HDL-cholesterol levels http://bit.ly/3uN1pF #SS09 #aha09

2 years ago...

FDA Urges Caution on Heart Findings from ADHD Drug Study | Psych Central News

psychcentral.com — “The U.S. Food and Drug Administration (FDA) urged caution on interpreting the findings from a new study published on Monday that showed an increase in the riskView full resource at psychcentral.com

  • View Related
  • Share

Most Recently Shared on June 15, 2009 at 8:13 pm By:

psychcentral Psych Central Health Site

Psychology Headline: FDA Urges Caution on Heart Findings from ADHD Drug Study @http://is.gd/12Jyj

3 years ago...

Stephen Colbert for FDA Commissioner? - Health Blog - WSJ

feeds.wsjonline.com — “This week the comedian joked of the Jupiter study on a statin taken by people with normal cholesterol: "This is a great breakthrough in the battle to find things to prescribe to people who don't need them."View full resource at feeds.wsjonline.com

  • View Related
  • Share

Most Recently Shared on November 15, 2008 at 2:15 pm By:

Advertisement